Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients (Q34316720)

25269624

1 August 2017

title

Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients (English)

1 reference

1 August 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Dariusz Lange

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

6

Barbara W Chwirot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Justyna Urban

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Grzegorz Szatkowski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Agata Stanek-Widera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

English

0 references

publication date

30 September 2014

1 reference

1 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

732

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

The specificity and patterns of staining in human cells and tissues of p16INK4a antibodies demonstrate variant antigen binding

4 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

COX2 overexpression is a prognostic marker for Stage III breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Hallmarks of Cancer: The Next Generation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Expression of cyclooxygenase-2 in human breast cancer: relationship with HER-2/neu and other clinicopathological prognostic factors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Cyclooxygenase-2: a potential target in breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Prognostic impact of cyclooxygenase-2 in breast cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

p53 expression in normal paraffin-embedded tissue using different antibodies and antigen retrieval buffer systems

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4192334

Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-732

Cyclooxygenase-2 expression correlates with diminished survival in invasive breast cancer treated with mastectomy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-732

Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-732

Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-732

Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-732

Lack of prognostic effect of Cox-2 expression in primary breast cancer on short-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-732

Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-732

Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-732

Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-732

HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-732

Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue

21 January 2018

1 reference

12 December 2020

COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients

1 reference

12 December 2020

Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact

1 reference

12 December 2020

Cyclooxygenase-2 immunohistochemistry in human melanoma: differences between results obtained with different antibodies

1 reference

12 December 2020

Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study

1 reference

12 December 2020

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-14-732

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

25269624

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269624%20AND%20SRC:MED&resulttype=core&format=json